|
TBC1D9B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.039300E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.364000E-03 |
| Normal-vs-Stage2 |
3.045600E-01 |
| Normal-vs-Stage3 |
2.539400E-03 |
| Normal-vs-Stage4 |
5.445800E-02 |
| Stage1-vs-Stage2 |
1.426030E-01 |
| Stage1-vs-Stage3 |
4.385800E-01 |
| Stage1-vs-Stage4 |
5.313200E-01 |
| Stage2-vs-Stage3 |
9.166000E-02 |
| Stage2-vs-Stage4 |
4.924400E-01 |
| Stage3-vs-Stage4 |
2.876000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.537030E-03 |
| Normal-vs-AfricanAmerican |
4.687400E-01 |
| Normal-vs-Asian |
4.342200E-01 |
| Caucasian-vs-AfricanAmerican |
1.375180E-01 |
| Caucasian-vs-Asian |
3.493800E-02 |
| AfricanAmerican-vs-Asian |
9.248800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.050200E-02 |
| Normal-vs-Female |
1.615490E-03 |
| Male-vs-Female |
3.187200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.423760E-03 |
| Normal-vs-Age(41-60Yrs) |
4.877000E-03 |
| Normal-vs-Age(61-80Yrs) |
5.359600E-02 |
| Normal-vs-Age(81-100Yrs) |
8.094600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.724400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.774220E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.965200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.969200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.305600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.867400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.231380E-01 |
| Classical-VS-Follicular |
5.363400E-01 |
| Classical-VS-Other |
9.149800E-02 |
| Classical-VS-Normal |
1.295940E-02 |
| Tall-VS-Follicular |
4.153800E-01 |
| Tall-VS-Other |
4.150000E-01 |
| Tall-VS-Normal |
6.757900E-03 |
| Follicular-VS-Other |
2.521600E-01 |
| Follicular-VS-Normal |
2.584400E-02 |
| Other-VS-Normal |
1.943600E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.708110E-02 |
| Normal-vs-N1 |
2.202200E-04 |
| N0-vs-N1 |
2.720100E-02 |
|
|
